Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/ijd.17033 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Adalimumab-induced optic neuritis: A rare side effect of biological therapy.
Int J Dermatol
March 2024
Dermatology Unit - IRCCS, Azienda Ospedaliero-Universitaria, Policlinico Sant'Orsola-Malpighi, Bologna, Italy.
Adalimumab-induced myasthenia gravis: case-based review.
Rheumatol Int
November 2020
Department of Internal Medicine, Medical School, Rheumatology Clinic, University of Ioannina, 45110, Ioannina, Greece.
Myasthenia gravis (MG) is an autoimmune disease characterised by the presence of acetylcholine receptor antibodies and by blocking the transmission of the signal in the neuromuscular junction causing muscle weakness. It can be associated with several autoimmune diseases and certain drugs, between them Etanercept an anti-tumour necrosis factor (TNF) agent. A 42-year-old woman with rheumatoid arthritis (RA) refractory to methotrexate, was treated with adalimumab (ADA), a human monoclonal antibody against the TNF, in a dosage scheme of 40 mg every 14 days subcutaneously.
View Article and Find Full Text PDFAdalimumab-induced remission of anterior scleritis: a very rare late manifestation of Takayasu arteritis.
Rheumatology (Oxford)
December 2015
Rheumatology Section, Vascultis Centre, Hammersmith Hospital, Imperial College Healthcare NHS Trust and
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!